Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Comet Bio
London, Ontario, Canadacomet-bio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Clinical studies have shown Arrabina arabinoxylan fiber supports healthy blood glucose levels, immune health, and growth of beneficial bifidobacteria in the gut. The ingredient has superior tolerability and functionality within the prebiotic market. The company’s products are used in a broad range of food and beverage applications with no negative impact on taste or performance. Arrabina has been clinically proven for its benefits.
- Therapeutic areas
- GastroenterologyEndocrinologyImmunology
- Modalities
- Prebiotic dietary fiber ingredientSustainable sweetener ingredient
- Industry
- Food & Nutrition
02
Partnerships
RE Energy (manufacturing facility expansion in Denmark)
Beyond the preview
Go deeper on Comet Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Comet Bio.